Proanthocyanidin protects against cisplatin-induced nephrotoxicity

Phytotherapy Research

Volumn 23, Issue 12, 2009, Pages 1738-1741

  Sayed, Ahmed Amir Radwan ^a  

^a Minia University ^*  (Egypt)

Author keywords

Cisplatin; Nephrotoxicity; Proanthocyanidins

Indexed keywords

CISPLATIN; CREATININE; GLUTATHIONE; INTERLEUKIN 6; MALONALDEHYDE; NOXYLIFE; PROANTHOCYANIDIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; UREA BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; CISPLATIN; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; INTERLEUKIN-6; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; OXIDATIVE STRESS; PROANTHOCYANIDINS; SUPEROXIDE DISMUTASE; UREA;

MUS;

EID: 73449101842     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2833     Document Type: Article

References (32)

1. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. 1997. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 95: 179-189.
2. Bagchi D, Garg A, Krohn RL et al. 1998. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 30: 771-776.
3. Buege AJ, Aust SD. 1978. Microsomal lipid peroxidation. Methods Enzymol 52: 302-310.
4. Davis CA, Nick HS, Agarwal A. 2001. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12: 2683-2690.
5. Dickey DT, Wu YJ, Muldoon LL, Neuwelt EA. 2005. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 314: 1052-1058.
6. Fine AM. 2000. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev 5: 144-151.
7. Fiorina P, Ansari MJ, Jurewicz M et al. 2006. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 17: 716-723.
8. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. 1993. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457.
9. Hah SS, Stivers KM, de Vere White RW, Henderson PT. 2006. Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry. Chem Res Toxicol 19: 622-626.
10. Kaushal GP, Kaushal V, Hong X, Shah SV. 2001. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 60: 1726-1736.
11. Kielar ML, John R, Bennett M et al. 2005. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16: 3315-3325.
12. Lebwohl D, Canetta R. 1998. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34: 1522-1534.
13. Li WG, Zhang XY, Wu YJ, Tian X. 2001. Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds. Acta Pharmacol Sin 22: 1117-1120.
14. Maliakel DM, Kagiya TV, Nair CK. 2008. Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and α-tocopherol. Exp Toxicol Pathol 60: 521-527.
15. Matsushima H, Yonemura K, Ohishi K, Hishida A. 1998. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 131: 518-526.
16. Morcos M, Schlotterer A, Sayed AAR et al. 2008. Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-κB activation in cultured human proximal tubular epithelial cells. Horm Metab Res 40: 1-8.
17. Moron MS, Depierre JW, Mannervik B. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 67: 582-589.
18. Murray M, Pizzorno J. 1999. Procyanidolic oligomers. In The Textbook of Natural Medicine, 2nd edn, Murray M, Pizzorno J (eds). Churchill Livingston: London, 899-902.
19. Nishikimi M, Roa NA, Yogi K. 1972. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46: 849-854.
20. Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P. 1998. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther 23: 385-389.
21. Okhawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissue by thiobarbituric acid. Anal Biochem 95: 355-358.
22. Pugh CW, Ratcliffe PJ. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-684.
23. Ramesh G, Reeves WB. 2002. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110: 835-842.
24. Ramesh G, Reeves WB. 2003. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 54: F610-F618.
25. Ramesh G, Zhang B, Uematsu S, Akira S, Reeves WB. 2007. Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice. Am J Physiol Renal Physiol 293: F325-F332.
26. Ravi RS, Somini SM, Rybak LP. 1995. Mechanism of cisplatin ototoxicity. Antioxidant system. Pharmacol Toxicol 76: 386-394.
27. Sadzuka Y, Shoji T, Takino Y. 1992. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43: 1872-1875.
28. Sayed AA. 2008. Thymoquinone protects tubular epithelial cells against tubular injury. Cell Biochem Function 26: 374-380.
29. Sayed AA, Morcos M. 2007. Thymoquinone decreases NF κB activation in AGE activated tubular epithelial cells. Phytother Res 21: 898-899.
30. Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M. 1987. Stimulatory effect of cisplatin on lipid peroxidation in renal tissues. Jpn J Pharmacol 43: 247-252.
31. 2-induced chromosomal damage in human lymphoblastoid cells. Biol Pharm Bull 27: 1459-1461.
32. Viale M, Zhang JG, Pastrone I, Mariggio MA, Esposito M, Lindup WE. 1999. Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo. Anticancer Drugs 10: 419-428.